Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.


Kimyon G., Kalyoncu U., Kiraz S., Bes C., Coşkun N., Yağiz B., ...Daha Fazla

Clinical and experimental rheumatology, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier

  • Cilt numarası:
  • Basım Tarihi: 2020
  • Dergi Adı: Clinical and experimental rheumatology